- Home
- HRMY
HRMY
Harmony Biosciences Holdings Inc.
as 04-18-2025 1:37pm EST
| Founded: | 2017 | Country: | United States |
| Employees: | N/A | City: | PLYMOUTH MEETING |
| Market Cap: | N/A | IPO Year: | 2020 |
| Target Price: | $54.00 | AVG Volume (30 days): | 809.0K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 8 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | 2.51 | EPS Growth: | 17.84 |
| 52 Week Low/High: | $26.47 - $41.61 | Next Earning Date: | 04-29-2025 |
| Revenue: | $714,734,000 | Revenue Growth: | 22.80% |
| Revenue Growth (this year): | 20.06% | Revenue Growth (next year): | 18.40% |
Stock Insider Trading Activity of Harmony Biosciences Holdings Inc. (HRMY)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Kapadia Sandip | HRMY | CHIEF FINANCIAL OFFICER | Apr 1 '25 | Sell | $32.80 | 6,987 | $227,385.94 | 0 | |
| Dierks Jeffrey | HRMY | CHIEF COMMERCIAL OFFICER | Mar 3 '25 | Sell | $32.92 | 4,869 | $159,089.50 | 500 | |
| Dierks Jeffrey | HRMY | CHIEF COMMERCIAL OFFICER | Jan 24 '25 | Sell | $37.61 | 14,754 | $551,575.01 | 500 | |
| Kapadia Sandip | HRMY | CHIEF FINANCIAL OFFICER | Jan 24 '25 | Sell | $38.05 | 1,775 | $67,547.27 | 0 | |
| Dayno Jeffrey M. | HRMY | PRESIDENT, CEO | Jan 21 '25 | Sell | $40.13 | 19,293 | $774,245.45 | 0 | |
| Kapadia Sandip | HRMY | CHIEF FINANCIAL OFFICER | Jan 21 '25 | Sell | $40.18 | 25,000 | $1,004,597.50 | 0 |
Latest Harmony Biosciences Holdings Inc. News
HRMY Breaking Stock News: Dive into HRMY Ticker-Specific Updates for Smart Investing
Argus Research
4 days ago
HRMY: What does Argus have to say about HRMY?
Argus Research
11 days ago
HRMY: Lowering target price to $37.00
Business Wire
11 days ago
Harmony Biosciences Presents Promising Open-Label Extension Data of ZYN002 in Fragile X Syndrome
Insider Monkey
15 days ago
Harmony Biosciences Holdings, Inc. (HRMY): A Bull Case Theory
Business Wire
16 days ago
Harmony Biosciences Appoints Biotech Leader Ron Philip to Its Board of Directors
Argus Research
18 days ago
HRMY: Lowering target price to $42.00
Insider Monkey
24 days ago
Is Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) the Best Small Cap Stock to Buy Before They Explode?
Business Wire
24 days ago
Harmony Biosciences to Participate in 24th Annual Needham Virtual Healthcare Conference
Compare HRMY vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "HRMY Harmony Biosciences Holdings Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.